Closing Bell: Knight Therapeutics Inc down on Wednesday (GUD)
In today's trading, shares of Knight Therapeutics Inc opened at $5.69 and closed at $5.59. It traded at a low of $5.56 to a high of $5.69.
The price dipped -1.76% from the previous day's close of $5.69.
Today across North America, the TSX Composite closed -0.76% at 22639.57, the S&P 500 closed -0.16% at 5555.74, the Dow Jones Industrial Average closed -0.14% at 40358.09 and the Nasdaq Composite closed -0.06% at 17997.35.
Knight Therapeutics Inc has listed on the Toronto Stock Exchange (TSX) under the ticker GUD.
Trading volume was 55,372 on 311 total trades, while having an average volume of 48,210 over the last 5-days.
The TSX market on the whole today saw 1,249 price advancers against 3,959 declines and 110 unchanged.
During the prior 52 weeks, GUD.TO has traded as high as $6.22 (May 15,2024) and low as $4.35 (October 23,2023). Moreover, the shares have advanced 14.55% in 52 weeks, while they have boosted 7.71% year-to-date.
Following today's trading, Knight Therapeutics Inc has a market capitalization of $576.83 million on a float of 101,376 shares outstanding. Its annual EPS is $-0.16.
Knight Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Montreal, CAN.
Knight Therapeutics Inc is holding an average recommendation of "Moderate Buy" from 4.00 analysts according to Zacks. Currently, there are 3 buy ratings and 1 hold ratings for the stock.
AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..
